Clinical Trial Update: Standard of Care Versus Hemopatch® During Liver Resection [NA]

View source ↗

Summary

This document describes a clinical trial comparing standard of care versus Hemopatch during liver resection, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Hemopatch

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Liver Cancer, Hemorrhage Liver | NA | Status: UNKNOWN